Literature DB >> 30428263

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Shelby Daniel-Wayman1, Getahun Abate2, Daniel L Barber3, Luiz E Bermudez4,5, Rhea N Coler6,7, Michael H Cynamon8,9, Charles L Daley10, Rebecca M Davidson11, Thomas Dick12,13, R Andres Floto14, Emily Henkle15, Steven M Holland16, Mary Jackson17, Richard E Lee18, Eric L Nuermberger19,20, Kenneth N Olivier21, Diane J Ordway17, D Rebecca Prevots1, James C Sacchettini22, Max Salfinger23,24, Christopher M Sassetti25, Christine F Sizemore26, Kevin L Winthrop15,27, Adrian M Zelazny28.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30428263      PMCID: PMC6467310          DOI: 10.1164/rccm.201807-1273PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  45 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.

Authors:  Richard J Wallace; Barbara A Brown-Elliott; Steven McNulty; Julie V Philley; Jessica Killingley; Rebecca W Wilson; Deanna S York; Sara Shepherd; David E Griffith
Journal:  Chest       Date:  2014-08       Impact factor: 9.410

3.  Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

Authors:  David E Griffith; Barbara A Brown-Elliott; Brett Langsjoen; Yansheng Zhang; Xi Pan; William Girard; Kenwyn Nelson; James Caccitolo; Julio Alvarez; Sara Shepherd; Rebecca Wilson; Edward A Graviss; Richard J Wallace
Journal:  Am J Respir Crit Care Med       Date:  2006-07-20       Impact factor: 21.405

4.  The environment of "Mycobacterium avium subsp. hominissuis" microaggregates induces synthesis of small proteins associated with efficient infection of respiratory epithelial cells.

Authors:  Lmar Babrak; Lia Danelishvili; Sasha J Rose; Tiffany Kornberg; Luiz E Bermudez
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

5.  Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.

Authors:  Jakko van Ingen; Timothy Aksamit; Claire Andrejak; Erik C Böttger; Emmanuelle Cambau; Charles L Daley; David E Griffith; Lorenzo Guglielmetti; Steven M Holland; Gwen A Huitt; Won-Jung Koh; Christoph Lange; Philip Leitman; Theodore K Marras; Kozo Morimoto; Kenneth N Olivier; Miguel Santin; Jason E Stout; Rachel Thomson; Enrico Tortoli; Richard J Wallace; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2018-03-22       Impact factor: 16.671

6.  Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulent.

Authors:  Iman Halloum; Séverine Carrère-Kremer; Mickael Blaise; Albertus Viljoen; Audrey Bernut; Vincent Le Moigne; Catherine Vilchèze; Yann Guérardel; Georges Lutfalla; Jean-Louis Herrmann; William R Jacobs; Laurent Kremer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-06       Impact factor: 11.205

Review 7.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Authors:  D Rebecca Prevots; Theodore K Marras
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

8.  Increased risk of mycobacterial infections associated with anti-rheumatic medications.

Authors:  Sarah K Brode; Frances B Jamieson; Ryan Ng; Michael A Campitelli; Jeffrey C Kwong; J Michael Paterson; Ping Li; Alex Marchand-Austin; Claire Bombardier; Theodore K Marras
Journal:  Thorax       Date:  2015-04-24       Impact factor: 9.139

9.  Rifabutin Is Active against Mycobacterium abscessus Complex.

Authors:  Dinah Binte Aziz; Jian Liang Low; Mu-Lu Wu; Martin Gengenbacher; Jeanette W P Teo; Véronique Dartois; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

10.  Mycobacterium abscessus subsp. abscessus Is Capable of Degrading Pseudomonas aeruginosa Quinolone Signals.

Authors:  Franziska S Birmes; Timo Wolf; Thomas A Kohl; Kai Rüger; Franz Bange; Jörn Kalinowski; Susanne Fetzner
Journal:  Front Microbiol       Date:  2017-03-02       Impact factor: 5.640

View more
  20 in total

Review 1.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

Review 2.  Repositioning rifamycins for Mycobacterium abscessus lung disease.

Authors:  Uday S Ganapathy; Véronique Dartois; Thomas Dick
Journal:  Expert Opin Drug Discov       Date:  2019-06-14       Impact factor: 6.098

3.  Novel Screening System of Virulent Strains for the Establishment of a Mycobacterium avium Complex Lung Disease Mouse Model Using Whole-Genome Sequencing.

Authors:  Koji Furuuchi; Shintaro Seto; Hajime Nakamura; Haruka Hikichi; Akiko Miyabayashi; Keiko Wakabayashi; Kazue Mizuno; Teruaki Oka; Kozo Morimoto; Minako Hijikata; Naoto Keicho
Journal:  Microbiol Spectr       Date:  2022-05-17

4.  Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus.

Authors:  Matt D Johansen; Wassim Daher; Françoise Roquet-Banères; Clément Raynaud; Matthéo Alcaraz; Florian P Maurer; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

5.  Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.

Authors:  Dereje Abate Negatu; Andreas Beuchel; Abdeldjalil Madani; Nadine Alvarez; Chao Chen; Wassihun Wedajo Aragaw; Matthew D Zimmerman; Benoît Laleu; Martin Gengenbacher; Véronique Dartois; Peter Imming; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

Review 6.  Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK.

Authors:  Marc Lipman; Joanne Cleverley; Tom Fardon; Besma Musaddaq; Daniel Peckham; Roald van der Laan; Paul Whitaker; Jacqui White
Journal:  BMJ Open Respir Res       Date:  2020-06

Review 7.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

Review 8.  Recent advances in nontuberculous mycobacterial lung infections.

Authors:  David Horne; Shawn Skerrett
Journal:  F1000Res       Date:  2019-10-01

9.  Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Getahun Abate; Jack T Stapleton; Nadine Rouphael; Buddy Creech; Jason E Stout; Hana M El Sahly; Lisa Jackson; Francisco J Leyva; Kay M Tomashek; Melinda Tibbals; Nora Watson; Aaron Miller; Edward Charbek; Joan Siegner; Marcia Sokol-Anderson; Ravi Nayak; Greta Dahlberg; Pat Winokur; Ghina Alaaeddine; Nour Beydoun; Katherine Sokolow; Naomi Prashad Kown; Shanda Phillips; Arthur W Baker; Nicholas Turner; Emmanuel Walter; Elizabeth Guy; Sharon Frey
Journal:  Clin Infect Dis       Date:  2021-04-08       Impact factor: 20.999

10.  Extreme Drug Tolerance of Mycobacterium abscessus "Persisters".

Authors:  Yee-Kuen Yam; Nadine Alvarez; Mei-Lin Go; Thomas Dick
Journal:  Front Microbiol       Date:  2020-03-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.